Home › Dyskeratosis Congenita
Dyskeratosis Congenita clinical trials recruiting in the U.S.
8 studies for Dyskeratosis Congenita are recruiting participants at sites across the United States.
Recently updated studies
Cancer in Inherited Bone Marrow Failure Syndromes
RecruitingObservational studyHealthy volunteers welcome
1 Day – 100 Years · All sexes · Updated Sep 30, 2026 · NCT00027274Quercetin Dyskeratosis Congenita (DC)/Telomere Biology Disorders (TBD)
RecruitingPhase 1
Ages 2 and older · All sexes · Updated Sep 10, 2026 · NCT07628972Nucleoside Therapy in Patients With Telomere Biology Disorders
RecruitingPhase 1
Ages 1 to 70 · All sexes · Updated Aug 4, 2026 · NCT06817590Familial Investigations of Childhood Cancer Predisposition
RecruitingObservational study
All ages · All sexes · Updated Jun 17, 2026 · NCT03050268Investigation of the Genetics of Hematologic Diseases
RecruitingObservational study
All ages · All sexes · Updated Jun 9, 2026 · NCT02720679Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
RecruitingPhase 2
Up to age 65 · All sexes · Updated Jan 30, 2026 · NCT03579875Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
RecruitingPhase 2
2 Months – 55 Years · All sexes · Updated Dec 15, 2025 · NCT01962415Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures
RecruitingPhase 2
4 Months – 50 Years · All sexes · Updated Nov 28, 2025 · NCT04232085From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.